Reply to more on: the role of thrombin in gliomas
dc.contributor.author | Hua, Yang | en_US |
dc.contributor.author | Keep, Richard F. | en_US |
dc.contributor.author | Muraszko, Karin M. | en_US |
dc.contributor.author | Hoff, Julian T. | en_US |
dc.contributor.author | Xi, Guohua | en_US |
dc.date.accessioned | 2010-06-01T18:58:20Z | |
dc.date.available | 2010-06-01T18:58:20Z | |
dc.date.issued | 2006-01 | en_US |
dc.identifier.citation | HUA, Y.; KEEP, R. F.; MURASZKO, K. M.; HOFF, J. T.; XI, G. (2006). "Reply to more on: the role of thrombin in gliomas." Journal of Thrombosis and Haemostasis 4(1): 287-287. <http://hdl.handle.net/2027.42/72163> | en_US |
dc.identifier.issn | 1538-7933 | en_US |
dc.identifier.issn | 1538-7836 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72163 | |
dc.format.extent | 69829 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Inc | en_US |
dc.rights | 2006 International Society on Thrombosis and Haemostasis | en_US |
dc.title | Reply to more on: the role of thrombin in gliomas | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72163/1/j.1538-7836.2005.01729.x.pdf | |
dc.identifier.doi | 10.1111/j.1538-7836.2005.01729.x | en_US |
dc.identifier.source | Journal of Thrombosis and Haemostasis | en_US |
dc.identifier.citedreference | Hua Y, Tang L, Keep R, Schallert T, Fewel ME, Muraszko KM, Hoff J, Xi G. The role of thrombin in gliomas. J Thromb Haemost 2005; 3: 1917 – 23. | en_US |
dc.identifier.citedreference | Hua Y, Keep RF, Schallert T, Hoff JT, Xi G. A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model. Acta Neurochirurgica (Suppl) 2003; 86: 503 – 6. | en_US |
dc.identifier.citedreference | Arbit E. More on: the role of thrombin in gliomas. J Thromb Haemost 2006; 4: 287. | en_US |
dc.identifier.citedreference | Hursting MJ, Alford KL, Becker JC, Brooks RL, Joffrion JL, Knappenberger GD, Kogan PW, Kogan TP, McKinney AA, Schwarz Jr RP. Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor. Semin Thromb Hemost 1997; 23: 503 – 16. | en_US |
dc.identifier.citedreference | Kitaoka T, Hua Y, Xi G, Hoff JT, Keep RF. Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage. Stroke 2002; 33: 3012 – 8. | en_US |
dc.identifier.citedreference | Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 2005; 353: 1028 – 40. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.